Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 714.47 -0.66 (-0.09%) Market Cap: 78.51 Bil Enterprise Value: 71.42 Bil PE Ratio: 17.68 PB Ratio: 2.68 GF Score: 88/100

Regeneron Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 09, 2020 / 12:55PM GMT
Release Date Price: $571.15 (+1.65%)
Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. So thank you very much, everyone, for joining us today for 15th Annual Citi BioPharma Conference. This is our second session. Good morning to everyone.

My name is Mohit Bansal. I'm one of the biotech analysts here at Citi, and I'm very happy to have Regeneron team today, Regeneron management team today. We have Neil Stahl with us. He's the EVP of R&D. He has been associated with this company for a really long time and Justin Holko, VP, IR.

Thank you, Neil and Justin, for joining us today.

Justin Holko
Regeneron Pharmaceuticals, Inc. - VP of IR

Thanks, Mohit.

Neil Stahl
Regeneron Pharmaceuticals, Inc. - EVP of Research & Development

Thanks, Mohit. It's a pleasure to be here.

Questions & Answers

Mohit Bansal
Citigroup Inc., Research Division - Director and Analyst

Great. So maybe, Neil, just to start with. Like I said, you have been with this company for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot